Last reviewed · How we verify
NCT06656585
Exploring Virtual Reality As an Intervention for Food Selectivity: a Clinical Trial
NA trial testing Individual food selectivity protocol in Autism in 30 participants. Currently enrolling.
31 May 2025
Quick facts
| Lead sponsor | Istituto per la Ricerca e l'Innovazione Biomedica |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 September 2024 |
| Primary completion | 31 May 2025 |
| Estimated completion | 17 July 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Individual food selectivity protocol
- Traditional food selectivity protocol
Conditions studied
- Autism — all drugs for Autism →
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Sponsor
Istituto per la Ricerca e l'Innovazione Biomedica — full company profile →
Who can join
Adults 4 to 10, any sex, with Autism or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Food selectivity is a common challenge among children with Autism Spectrum Disorder (ASD), with significant impacts on their nutrition and well-being. The main purpose of this study is to promote children's active participation in mealtime routines and encourage experimentation with new foods through an approach that emphasizes joy and serenity during mealtimes. The study will involve children with ASD between the ages of 4 and 10 years, of both sexes. Food selectivity will be assessed through interviews with parents and the use of specially created cards. The protocol will include 45-minute sessions, twice a week, for a total of 48 sessions. The children will wear an Oculus headset and be exposed to the foods through this virtual reality tool, enhancing their engagement and willingness to try new foods in a fun and immersive way.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06656585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Individual food selectivity protocol
Trials testing the same drug.
- NCT06179940 — Food Selectivity Protocol for Children With Autism Spectrum Disorders · NA · unknown
Other recruiting trials for Autism
Currently open trials in the same condition.
- NCT07367256 — Using Virtual Reality to Improve Emotion Understanding in Children With Autism · NA · recruiting
- NCT06853665 — The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine · Phase 4 · recruiting
- NCT06523387 — Online Pivotal Response Treatment Training in Autism Spectrum Disorder · NA · recruiting
- NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
- NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting
Other Istituto per la Ricerca e l'Innovazione Biomedica trials
Trials by the same sponsor.
- NCT07367256 — Using Virtual Reality to Improve Emotion Understanding in Children With Autism · NA · recruiting
- NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting
- NCT07456475 — Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility · NA · active not recruiting
- NCT06872229 — The Impact of Sensory Integration on Attention in Autism · recruiting
- NCT06799962 — AI and VR Devices for Eating Behavior Rehabilitation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06656585 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto per la Ricerca e l'Innovazione Biomedica
- Last refreshed: 24 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06656585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing